Otolaryngology Doctors in Anderson, IN Accepting Medicare

7 Otolaryngology doctors found. Showing 1 - 7

Dr. Fernando Javier Morell Diaz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961

James Milligan, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961    Fax: 765-642-0408

Scott C Swim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961

Joshua B Greene, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961

Ronald J Blevins, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961

Jennifer Phan, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3113 N Broadway Street, Anderson, IN 46012 Phone: 765-298-4660

Peter Nielsen Schilt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 115, Anderson, IN 46016 Phone: 765-643-6961

News Archive

AbbVie's ABT-493 and ABT-530 achieve high SVR rates in GT1 chronic HCV patients who failed previous therapy with DAAs

AbbVie, a global biopharmaceutical company, today announced that 91 percent (n=20/22) of genotype 1 (GT1) chronic hepatitis C virus (HCV) infected patients who failed previous therapy with direct-acting antivirals (DAAs) achieved SVR12 with 12 weeks of ABT-493 and ABT-530 with ribavirin (RBV) in the primary intent-to-treat analysis.

CU Cancer Center study reports 'robust antitumor activity' of TAK-733 drug in mouse models of colorectal cancer

A University of Colorado Cancer Center study recently published online ahead of print in the journal Oncotarget reports "robust antitumor activity" of the drug TAK-733 in cells and mouse models of colorectal cancer.

Safeguard Scientifics' annual shareholder meeting at Pennsylvania, USA will have live webcast

Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its annual meeting of shareholders, to be held on Friday, August 28, 2009 at 8 a.m. EDT at Dolce Valley Forge, King of Prussia, PA, will be webcast live and available via toll-free conference call.

UTHealth professor awarded $1 million grant from Stryker Neurovascular for stroke research

A $1 million grant for stroke research has been awarded from Stryker Neurovascular to Amrou Sarraj, M.D., assistant professor of neurology at The University of Texas Health Science Center at Houston.

Pelosi relationship with Obama strained, Sen. Kyl and Wyden see hope for bipartisanship

House Speaker Nancy Pelosi's relationship with President Barack Obama is becoming strained over roadblocks Democrats are seeing on legislation and the treatment some Democrats view as "cavalier" from the White House, Politico reports. "For months, the California lawmaker has been pushing Obama hard in private while praising him in public. But now she's being more open in her criticism, in part because she feels the White House was wrong — in the wake of the Democrats' loss in Massachusetts — to push the Senate health care bill on the House when she knew there was no way it would pass.

Read more Medical News

› Verified 2 days ago